CDH1 and breast carcinoma: The loss of SNX27 reduced tumor growth and proliferation in breast cancer cells and its ability to minimize aggressiveness and invasive capacity via modulation of EMT marker, Vimentin, and cell–cell junction markers, E-cadherin and Claudin-5 [186].